Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Trident Texofab: Board Meeting Intimation for Consideration And Approval Of Un-Audited Standalone Financial Results For The Quarter Ended June 30 2026
News Announcement

Trident Texofab: Board Meeting Intimation for Consideration And Approval Of Un-Audited Standalone Financial Results For The Quarter Ended June 30 2026

04-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Trident Texofab

Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve un-audited standalone financial results for the quarter ended June 30 2026.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan